PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer

NCT01723774 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: PD0332991
DRUG: Anastrozole
DRUG: Goserelin
PROCEDURE: Surgery (standard of care)
PROCEDURE: Tumor biopsy

Sponsor

Washington University School of Medicine

Collaborators

[object Object]